Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase

Tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO) constitute an important, yet relatively poorly understood, family of heme-containing enzymes. Here, we report extensive structural and biochemical studies of the Xanthomonas campestris TDO and a related protein SO4414 from Shewanella oneidensis, including the structure at 1.6-Å resolution of the catalytically active, ferrous form of TDO in a binary complex with the substrate l-Trp. The carboxylate and ammonium moieties of tryptophan are recognized by electrostatic and hydrogen-bonding interactions with the enzyme and a propionate group of the heme, thus defining the l-stereospecificity. A second, possibly allosteric, l-Trp-binding site is present at the tetramer interface. The sixth coordination site of the heme-iron is vacant, providing a dioxygen-binding site that would also involve interactions with the ammonium moiety of l-Trp and the amide nitrogen of a glycine residue. The indole ring is positioned correctly for oxygenation at the C2 and C3 atoms. The active site is fully formed only in the binary complex, and biochemical experiments confirm this induced-fit behavior of the enzyme. The active site is completely devoid of water during catalysis, which is supported by our electrochemical studies showing significant stabilization of the enzyme upon substrate binding.

[1]  H. Sugimoto,et al.  Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Andrew Mellor,et al.  Indoleamine 2,3 dioxygenase and regulation of T cell immunity. , 2005, Biochemical and biophysical research communications.

[3]  O. Takikawa Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. , 2005, Biochemical and biophysical research communications.

[4]  Michael Platten,et al.  Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite , 2005, Science.

[5]  A. Munro,et al.  Redox and spectroscopic properties of human indoleamine 2,3-dioxygenase and a His303Ala variant: implications for catalysis. , 2005, Biochemistry.

[6]  G. Prendergast,et al.  Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy , 2005, Nature Medicine.

[7]  Jonathan P. Clark,et al.  4-Cyanopyridine, a Versatile Spectroscopic Probe for Cytochrome P450 BM3* , 2004, Journal of Biological Chemistry.

[8]  D. Munn,et al.  Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.

[9]  D. Rousseau,et al.  Crystal Structure of the Dioxygen-bound Heme Oxygenase from Corynebacterium diphtheriae , 2004, Journal of Biological Chemistry.

[10]  R. Schwarcz The kynurenine pathway of tryptophan degradation as a drug target. , 2004, Current opinion in pharmacology.

[11]  C. Uyttenhove,et al.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase , 2003, Nature Medicine.

[12]  R. Truscott,et al.  Asp274 and His346 Are Essential for Heme Binding and Catalytic Function of Human Indoleamine 2,3-Dioxygenase* , 2003, Journal of Biological Chemistry.

[13]  U. Grohmann,et al.  Tolerance, DCs and tryptophan: much ado about IDO. , 2003, Trends in immunology.

[14]  Andrew C. Terentis,et al.  The Heme Environment of Recombinant Human Indoleamine 2,3-Dioxygenase , 2002, The Journal of Biological Chemistry.

[15]  G Jogl,et al.  COMO: a program for combined molecular replacement. , 2001, Acta crystallographica. Section D, Biological crystallography.

[16]  M. Walker,et al.  Expression and purification of recombinant human indoleamine 2, 3-dioxygenase. , 2000, Protein expression and purification.

[17]  D E McRee,et al.  XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.

[18]  Russ Miller,et al.  The design and implementation of SnB version 2.0 , 1999 .

[19]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[20]  D. Munn,et al.  Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.

[21]  J. Dawson,et al.  Heme-Containing Oxygenases. , 1996, Chemical reviews.

[22]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[23]  C. Sander,et al.  Protein structure comparison by alignment of distance matrices. , 1993, Journal of molecular biology.

[24]  M. Sono,et al.  1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. , 1991, Archives of biochemistry and biophysics.

[25]  W. Hendrickson Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. , 1991, Science.

[26]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[27]  M. Sono Enzyme kinetic and spectroscopic studies of inhibitor and effector interactions with indoleamine 2,3-dioxygenase. 2. Evidence for the existence of another binding site in the enzyme for indole derivative effectors. , 1989, Biochemistry.

[28]  T. Tatusova,et al.  Reannotation of Shewanella oneidensis genome. , 2003, Omics : a journal of integrative biology.

[29]  Thomas C Terwilliger,et al.  SOLVE and RESOLVE: automated structure solution and density modification. , 2003, Methods in enzymology.

[30]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[31]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[32]  O. Hayaishi,et al.  [26] Indoleamine 2,3-dioxygenase , 1987 .

[33]  Y. Ishimura,et al.  Regulatory control and catalytic mechanisms of L-tryptophan 2,3-dioxygenase (pyrrolase). , 1980, Advances in enzyme regulation.

[34]  Y. Ishimura [52] l-tryptophan 2,3-dioxygenase (tryptophan pyrrolase) (pseudomonas fluorescens) , 1970 .